| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |